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Background. Sleep beneﬁts memory consolidation. Here, we tested the beneﬁcial effect of sleep on memory consolida-
tion following exposure psychotherapy of phobic anxiety.
Method. A total of 40 individuals afﬂicted with spider phobia according to DSM-IV underwent a one-session virtual
reality exposure treatment and either slept for 90min or stayed awake afterwards.
Results. Sleep following exposure therapy compared with wakefulness led to better reductions in self-reported fear
(p=0.045, d=0.47) and catastrophic spider-related cognitions (p=0.026, d=0.53) during approaching a live spider, both
tested after 1 week. Both reductions were associated with greater percentages of stage 2 sleep.
Conclusions. Our results indicate that sleep following successful psychotherapy, such as exposure therapy, improves
therapeutic effectiveness, possibly by strengthening new non-fearful memory traces established during therapy. These
ﬁndings offer an important non-invasive alternative to recent attempts to facilitate therapeutic memory extinction and
consolidation processes with pharmacological or behavioral interventions.
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Introduction
Sleep beneﬁts emotional learning in various tasks, such
as learning negative memories (Pace-Schott et al. 2009),
habituation to emotional stimuli (Pace-Schott et al.
2011), or retention of previously encoded emotional
pictures or texts (Wagner et al. 2001; Payne et al.
2008; Nishida et al. 2009). Effects of a 3-h nap following
emotional learning are even detectable 4 years later
(Wagner et al. 2006). In addition to strengthening of
the content of the emotional memory, sleep plays an
important role in reducing the degree of emotional
arousal associated with the memory (Walker & van
der Helm, 2009; Pace-Schott et al. 2011; van der Helm
et al. 2011b). Collectively, these studies indicate that
sleep plays an important role in modulation and inte-
gration of emotional memories (Walker, 2008, 2009;
Wamsley & Stickgold, 2010). More speciﬁcally, sleep-
dependent memory processing relies on an ofﬂine
reactivation and consolidation during which new and
initially labile memories encoded during wakefulness
are transformed into more stable representations and
gradually integrated in cortical networks of pre-
existing long-term memories (Diekelmann & Born,
2010). Signiﬁcant effects of sleep on memory occur
after naps of 1–2 h (Mednick et al. 2003; Diekelmann
et al. 2009), and even after ultra-short naps of 6min
(Lahl et al. 2008; Nishida et al. 2009). A recent study
demonstrated signiﬁcant memory enhancements
following a 90-min, but not following a shorter
40-min sleep interval compared with wakefulness
(Diekelmann et al. 2012). Concerning sleep stage contri-
butions, non-rapid eye movement sleep is associated
with the strengthening of hippocampus-dependent
declarative memories (Stickgold, 2009), whereas rapid
eye movement (REM) sleep has been implicated in
the modulation of emotional memories and arousal
(Walker & van der Helm, 2009; van der Helm et al.
2011b) and the extinction of conditioned fear (Spoor-
maker et al. 2010, 2011).
Here, we test the beneﬁcial effect of sleep on mem-
ory consolidation following treatment of phobic
anxiety with exposure therapy. Exposure therapy is a
prime exemplar of a learning situation during which
new memory traces are formed that need to be
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consolidated and integrated with pre-existing mem-
ories and experiences. It has consistently been shown
to be effective in the treatment of phobia, which rep-
resents one of the most frequent types of mental dis-
orders (Magee et al. 1996; Ruhmland & Margraf,
2001; Choy, 2007; Norton & Price, 2007). However,
some patients do not respond to this form of treatment,
achieve only partial symptom remission, or fear
often returns following initially successful therapy
(Mystkowski et al. 2002, 2006; Craske & Mystkowski,
2006). Consequently, the development of novel and
innovative approaches to increase therapeutic effec-
tiveness is a primary challenge in current research on
treatment of anxiety disorders (Ressler et al. 2004;
McNally, 2007; De Quervain, 2011).
One promising candidate for enhancing therapeutic
effectiveness is sleep and its potential beneﬁcial inﬂu-
ence on memory formation. There is now preliminary
evidence that a period of sleep following a simulated
version of exposure therapy may promote retention
and generalization of extinction learning in individuals
with phobic anxiety (Pace-Schott et al. 2012). To
the best of our knowledge, the current study is
the ﬁrst to extend the result of sleep-induced memory
consolidation to a clinical context of patients afﬂicted
with speciﬁc phobia according to the Diagnostic and
Statistical Manual of Mental Disorders; Fourth Ed-
ition (DSM-IV; APA, 1994) employing a one-session
virtual exposure therapy. We treated 40 patients with
one-session virtual exposure to spiders. Virtual reality
(VR) treatment of phobias effectively reduces phobic
fear (Emmelkamp et al. 2001; Powers & Emmelkamp,
2008; Wamsley & Stickgold, 2010), and previous
studies indicate that 1-day exposure sessions may be
sufﬁcient in order to markedly reduce phobic fear
(Ost, 1996; Ost et al. 1997). In concordance with the
hypothesized role of sleep in ofﬂine consolidation of
emotional memories, we hypothesized that sleep fol-
lowing an exposure therapy session compared with
wakefulness leads to greater reductions in subjective
anxiety and catastrophic spider-related cognitions,
as well as greater increases in behavioral approach
towards a live spider.
Method
Subjects
Inclusion criteria were a diagnosis of speciﬁc phobia
according to DSM-IV (APA, 1994), including a subjec-
tive interference score of at least 3 out of 10 (0=not at
all interfering; 10=extremely interfering), no current
sleep problems, and no alcohol or drug dependence.
Of 80 subjects recruited via newspaper advertisements,
20 failed to meet these inclusion criteria, six chose not
to participate, and four wished to discontinue follow-
ing the initial assessment. A total of 50 individuals
underwent the one-session VR exposure treatment.
Of these, however, ﬁve produced a faulty electro-
encephalogram (EEG) signal and could not be
included as sleep was not recorded, two subjects did
not return for any follow-up, and three subjects were
excluded following an outlier analysis indicating
implausible questionnaire scores. Data from 40 subjects
were included in the analyses. Subjects received 50
Swiss francs (approximately US$55) as compensation
for their participation.
Procedure
The ethics committee of the University of Basel
approved the study. Participation included three
appointments: an initial screening session to assess
phobia symptoms, absence of depression, psychosis
and sleep-related variables, including medication
intake that could interfere with sleep, and behavioral
approach towards a live spider before treatment (pre-
treatment assessment), a single VR exposure treatment
session (treatment), and an assessment at the labora-
tory 7 days following treatment (1-week follow-up).
Pre-treatment assessments took place at the laboratory
1 week prior to the scheduled exposure session. After
describing the study to participants, written informed
consent was obtained. Participants then completed a
structured clinical interview in order to assess whether
they fulﬁlled diagnostic criteria for speciﬁc phobia
and performed a behavioral approach task (BAT, see
Mystkowski et al. 2002). During the BAT, they were
asked to approach a caged tarantula. The widely
used measure of self-reported fear, the Subjective
Units of Distress Scale (SUDS; Wolpe, 1966) was
used. This was a 100-point scale on which participants
rated their level of fear/anxiety. Using the same scale,
they rated the severity of their personal most cata-
strophic spider-related cognition. A behavioral avoid-
ance measurement, i.e. closest distance in cm to a
spider, was also taken. In addition, participants ﬁlled
in questionnaires, and were then all set up for a
45-min nap in the laboratory in order to get accus-
tomed to the laboratory setting. Before they left, they
received some psychoeducative material, i.e. a short
description about exposure therapy.
VR exposure therapy session
Exposure treatments took place at a standardized
time for all participants (12.15 hours) in a temperature-
controlled, sound-attenuated and darkened room
connected to an adjoining control room. Prior to the
session, physiological sensors, head-mounted display
and headphones were adjusted. Via the display,
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participants were exposed to spiders in a VR environ-
ment (Virtual Reality Medical Center, San Diego, CA,
USA) that was simulated by a computer program. A
sensor registered head movements and altered the
display to reproduce a change in gaze direction. The
therapist controlled the treatment via a computer in
the control room and adapted a standardized therapy
protocol depending on each participant’s strength of
self-reported fear. Participants were guided through a
VR environment with different rooms of an apartment
that contained various spiders. They were systemati-
cally guided through the environment and had to
pass the same predeﬁned locations. Participants were
instructed to move their heads and look around at
various points. They started the exposure session by
entering the virtual apartment. Participants stayed in
a given location for 60 s, or until their SUDS, taken
every 30 s, were reduced by 20%. A maximum of 13
stations was available and participants spent a total
of 45min in the virtual environment. This highly stan-
dardized exposure protocol was similar to the one
used in a study of VR exposure in height phobia (De
Quervain et al. 2011).
Following the exposure session, participants were
randomly assigned by a pre-generated list of random
assignments to either sleep or wake condition by a
third person blind to therapy procedures and outcome.
These experimental groups differed marginally in
their spider phobia severity, and there were no differ-
ences in trait anxiety or depression. They were then set
up to either sleep (sleep group) or to watch a neutral
video (documentary of European Cities by The
National Geographic Society, wake group), both for
90min (see Diekelmann et al. 2012), in a different room
at the laboratory. Finally, all participants completed a
BAT approximately 5min following the sleep period
or watching the neutral video, respectively.
Follow-up assessment
Patients returned to the laboratory 1 week following
the exposure session, where they completed another
BAT and ﬁlled in questionnaires.
Sleep recordings
Sleep was recorded using a portable EEG
machine (SOMNOscreen EEG 10/20; SOMNOmedics,
Germany). EEG was recorded for 90min in both con-
ditions (sleep, wake) on Fz, Cz, Pz and Oz channels
according to the international 10/20 system. Sleep
parameters and architecture were determined using a
validated automatic scoring algorithm (Anderer et al.
2010) according to standard criteria of the American
Association of Sleep Medicine. EEG recordings were
examined individually to assess the occurrence of
sleep during both conditions.
Sleep recordings revealed that only one participant
fell asleep in the video control group (time in stage
N2 sleep: 11min), and he was transferred to the sleep
group. In the sleep group, two subjects were unable
to reach stable sleep for more than 5min (time in
stage N2 sleep: 1 and 3min, respectively), and they
were transferred to the wake group. Thus, in our
analysis, the sleep group consisted of 21 participants
(18 female, three male participants) and the wake
group consisted of 19 participants (16 female, three
male participants). The groups did not differ signiﬁ-
cantly in terms of age, sex and other demographic
and clinical characteristics, including trait anxiety,
depression and initial behavioral approach scores (all
p>0.20, see Table 1). There was a marginal difference
in initial severity of phobia symptoms (p=0.093).
Importantly, there were no signiﬁcant group differ-
ences in self-reported exposure to spiders in partici-
pants’ everyday lives during the follow-up period,
neither in frequency of any spider exposure (p=0.430)
nor in active exposure seeking (p=0.635).
Interview and questionnaire measures
Diagnostic criteria for speciﬁc phobia were assessed
by graduate-level clinical psychologists using a struc-
tured Diagnostic Interview for Mental Disorders
(DIPS; Schneider & Margraf, 2006). The DIPS is
a reliable interview, with good construct validity
(Suppiger et al. 2008). It is based on a German trans-
lation and extension of the Anxiety Disorders
Interview Schedule for DSM-IV, and is designed to
assess the most relevant mental disorders according
to DSM-IV, text revision (DSM-IV-TR). A sum score
was calculated indexing phobia severity. This score
summed answers to questions on subjective spider
anxiety, physiological arousal, avoidance, and interfer-
ence with respect to spider anxiety. The following self-
report questionnaires were administered: chronotype
was assessed with the German version of the
Morningness–Eveningness Questionnaire (Horne &
Ostberg, 1976); excessive daytime sleepiness was
assessed using the Epworth Sleepiness Scale (Johns,
1994); and sleep quality was assessed using the
Pittsburgh Sleep Quality Index (Buysse et al. 1989).
The Spider Phobia Beliefs Questionnaire (Arntz et al.
1993) assessed catastrophic spider-related cognitions
(e.g. ‘The spider is deadly’, or ‘The spider will attack
me’). Depressive symptoms were assessed with the
Beck Depression Inventory (BDI-II; Beck & Steer,
1987). Presence in the virtual environment, i.e. the
level of connection an individual feels with the virtual
environment, is a critical construct for the experience of
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anxiety and for successful response to the VR (Price
et al. 2011) and was assessed with the Immersive
Tendencies Questionnaire (Scheuchenpﬂug, 2001).
Statistical analysis
Statistical analyses were performed with PASW 19.0
for Macintosh (SPSS Inc., USA). Group differences in
demographic, clinical and sleep-related variables, and
initial BAT scores were analysed with analysis of var-
iance, χ2 or Mann–Whitney U tests. Separate general
linear models (GLM) were calculated as multivariate
tests for repeated measures to assess the effect of
group and time on BAT outcome variables (immediate
and 1-week change scores in fear, cognition, avoid-
ance), controlling for initial phobia severity and subjec-
tive presence in the virtual environment. In an
explorative analysis, we correlated selected sleep indi-
ces with subjective anxiety and catastrophic cognition
change scores. Effect sizes were calculated for signiﬁ-
cant results.
Results
Effects of one-session VR exposure
In the overall sample, we found a signiﬁcant reduction
of self-reported fear from pre- to post-exposure and
1-week follow-up assessment in several variables.
First, subjective anxiety when approaching a live
tarantula was reduced (SUDS rating, range 0–100):
mean (S.D.)pre=50.08 (26.86) v. mean (S.D.)post =25.17
(22.61) (F1,39 =39.94, p<0.001); mean (S.D.)follow-up=
20.08 (22.52) (F1,39=41.79, p<0.001, v. pre). The effect
size from pre-treatment to post-treatment assessment
was d=1.01, and from pre-treatment to follow-up was
d=1.22. Spider-related negative beliefs, as measured
during the BAT and by the Spider Phobia Beliefs
Questionnaire signiﬁcantly decreased during treat-
ment: BAT – mean (S.D.)pre=34.17 (31.87) v. mean
(S.D.)post =24.15 (27.79) (F1,39=3.43, p=0.071); mean
(S.D.)follow-up=18.72 (24.10) (F1,39=10.18, p=0.003);
questionnaire – mean (S.D.)pre=20.64 (3.96) v. mean
(S.D.)follow-up=16.51 (4.38) (F1,38 =39.94, p<0.001, d=1.0).
Subjects also moved closer to the spider (distance to
terrarium in cm) from pre- to post-exposure: mean
(S.D.)pre=95.05 (80.09) v. mean (S.D.)post =51.1 0 (48.06)
(F1,39=33.61, p<0.001, d=0.68), and to follow-up,
mean (S.D.)follow-up=39.30 (48.83) (F1,39=40.24, p<0.001,
d=0.87).
Sleep following VR exposure
Total sleep time during the assigned 90min in the
sleep group was 52.25min (S.D. =18.62min), with a
Table 1. Pre-treatment sociodemographic, clinical and sleep characteristics of the sleep versus the wake group
Variable
Sleep group
(n=21)
Wake group
(n=19) Statistics
Age, years 25.81 (6.96) 27.63 (9.77) F1,39=0.47, p=0.498
Sex, female, n (%) 18 (85.7) 16 (94.7) χ21=0.018, p=0.619
Work, full/part-time work, n (%) 18 (85.7) 18 (85.7) χ21=1.05, p=0.788
Alcohol, units per week 3.18 (3.26) 2.93 (2.49) F1,39=0.06, p=0.816
Smoking, no. cigarettes per week 37.60 (57.28) 19.40 (16.71) F1,39=0.47, p=0.514
Severity of phobia diagnosisa 5.24 (1.84) 4.00 (1.64) F1,39=3.11, p=0.093
Trait anxiety 47.38 (2.22) 47.32 (2.24) F1,39=0.10, p=0.927
BDI-II score 7.13 (6.38) 4.57 (3.60) F1,39=0.97, p=0.337
Epworth Sleepiness Scale score 9.57 (3.11) 8.16 (3.78) F1,39=1.68, p=0.202
Pittsburgh Sleep Quality Index total score 13.52 (1.40) 12.79 (0.98) F1,39=3.62, p=0.065
Chronotype, n (%)b
Morning type 2 (9.5) 2 (10.5) χ2=1.62, p=0.655
Neutral type 16 (76.2) 12 (63.2)
Evening type 2 (9.5) 5 (26.3)
Total sleep time, min 52.25 (18.62) 0.71 (2.15) F1,39=143.34, p<0.001
Sleep stage N1, min 10.17 (5.51) 0.42 (1.30) F1,39=56.45, p<0.001
Sleep stage N2, min 30.05 (12.05) 0.24 (0.75) F1,39=115.59, p<0.001
Slow-wave sleep, min 12.55 (14.06) 0 U=47.50, p<0.001
REM sleep, min 1.52 (3.18) 0 U=135.00, p=0.015
Data are given as mean (standard deviation) unless otherwise indicated.
BDI, Beck Depression Inventory; REM, rapid eye movement.
a Phobia symptom severity from clinical interview.
b Chronotype was assessed with the German version of the Morningness–Eveningness Questionnaire.
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mean sleep latency of 19.55min (S.D. =9.81min).
Average stage 2 sleep duration was 30.05min (S.D. =
12.05min); average slow-wave sleep duration was
12.55min (S.D. =14.06min). Mean duration of REM
sleep was 1.5min (S.D.=3.18min).
Effects of sleep on VR exposure outcome
The GLM testing the effect of group and time on fear
change scores revealed a signiﬁcant effect of time
(F1,36 =6.84, p=0.013), with greater reductions at
1-week compared with immediate follow-up, as well
as a signiﬁcant interaction between group and time
(F1,36 =4.30, p=0.045). For cognition change scores, the
GLM revealed a marginally signiﬁcant effect of time
(F1,36 =3.22, p=0.081), and a signiﬁcant interaction
between group and time (F1,36 =45.40, p=0.026). For
behavioral avoidance, the effect of time was non-
signiﬁcant (p=0.478), and the interaction between
group and time was marginally signiﬁcant (F1,36=
2.29, p=0.139). We followed up the signiﬁcant inter-
actions with post-hoc tests and found that sleep did
not affect immediate changes in subjective anxiety,
severity of catastrophic spider-related cognitions or
distance in approaching a live tarantula (all p values
>0.46). However, with regard to the long-term effects,
participants in the sleep group showed a stronger
reduction in subjective anxiety from post-exposure
assessment to follow-up assessment after 1-week as
compared with the wake group; reduction scores:
mean (S.D.)sleep=−9.14 (21.10) v. mean (S.D.)wake=
−0.63 (14.84) (F1,36=4.30, p=0.045, d=0.47). The sleep
group also showed greater reductions in catastrophic
cognitions at follow-up compared with post-exposure;
reduction scores: mean (S.D.)sleep=−10.76 (18.94)
v. mean (S.D.)wake=0.47 (16.85) (F1,36 =5.40, p=0.026,
d=0.53). The reduction in approach to the live spider
(cm) was marginally signiﬁcant; reduction scores:
mean (S.D.)sleep=−18.19 (32.70) v. mean (S.D.)wake=
−4.74 (27.19) (F1,36=2.29, p=0.139). Initial scores, as
well as immediate and 1-week change scores and
tests for group differences, are reported in Table 2.
Reductions of subjective anxiety and catastrophic
spider-related cognitions for the sleep versus the
wake group are displayed in Fig. 1.
The difference between changes in subjective anxiety
and negative cognition was not signiﬁcantly different
in either group (all p values>0.770). Neither sleep
quality, as indexed by the Pittsburgh Sleep Quality
Score, nor level of immersion in the VR setting was
signiﬁcantly related to any of the outcome scores (all
p values>0.210).
Sleep indices and VR exposure outcome
In an exploratory analysis, contributions of sleep
stage 2, slow-wave sleep and REM sleep to long-term
reductions in self-reported fear and catastrophic cogni-
tions in the BAT (change score from post-exposure to
follow-up assessment) were investigated. Those with
greater reduction in self-reported fear from post- to
follow-up assessment had greater percentages of
stage 2 sleep, again controlling for phobia severity
and presence in the VR environment (r=0.35, p=
0.03). Reduction of catastrophic cognitions was also
related to more stage 2 sleep (r=0.41, p=0.016).
Table 2. Initial self-reported fear, negative spider-related cognition and behavioral avoidance scores, and immediate and 1-week change scoresa
Variable Sleep group (n=21) Wake group (n=19) Statistics
Initial baseline scores
Self-reported fear 51.33 (26.07) 48.68 (28.34) F1,39=1.00, p=0.760
Most threatening cognition 35.00 (34.86) 33.26 (29.14) F1,39=0.03, p=0.866
Distance to spider, cm 102.10 (87.46) 87.26 (72.63) F1,39=0.34, p=0.565
Immediate change scores
Self-reported fear −24.29 (23.98) −25.58 (21.57) F1,39=0.11, p=0.740
Most threatening cognition −5.67 (36.34) −14.84 (31.99) F1,39=0.56, p=0.460
Distance to spider, cm −46.47 (51.16) −41.16 (45.36) F1,39=0.39, p=0.535
1-week change scores
Self-reported fear −9.14 (21.10) −0.63 (14.84) F1,39=4.30, p=0.045
Most threatening cognition −10.76 (18.94) +0.47 (16.85) F1,39=5.40, p=0.026
Distance to spider, cm −18.19 (32.70) −4.74 (27.19) F1,39=2.29, p=0.139
Data are given as mean (standard deviation).
a Initial baseline scores were assessed 1 week prior to the exposure session. Immediate change scores were calculated by
subtracting pre-exposure scores from immediate follow-up scores (assessed minutes after sleep/wake period); 1-week change
scores were calculated by subtracting immediate follow-up scores from 1-week follow-up scores; ranges for fear and cognition
scores were 0–100.
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There was no signiﬁcant correlation between percen-
tage of slow-wave sleep or REM sleep with change
in self-reported fear and catastrophic cognitions (all
p>0.12).
Discussion
It is generally established that sleep after learning
beneﬁts memory consolidation, but this knowledge
has not yet been applied to the context of emotional
learning in psychotherapy. Here we show that sleep
after VR exposure therapy improves the therapeutic
effectiveness in spider phobia. Patients who napped
after exposure therapy showed greater reductions in
subjective anxiety and catastrophic spider-related cog-
nitions at follow-up testing (after 1 week) as compared
with patients who stayed awake after the therapeutic
intervention. No differences were observed immedi-
ately after sleep or waking. The enhancing effects of
sleep after 1 week correlated with greater percentages
of stage 2 sleep, pointing to the importance of stage 2
sleep for this type of memory consolidation.
To our knowledge, this is the ﬁrst empirical test of
whether and how patients are able to sleep immedi-
ately following exposure therapy. Exposure sessions
tend to have substantial anxious arousal properties,
so that it might have been expected that sustained
arousal would prevent individuals from falling asleep
after therapy. Our results demonstrate that this was
not the case: mean sleep onset latency was around
20min, and individuals slept 50min on average during
the assigned 90-min period just after the exposure ses-
sion. It is conceivable that our speciﬁc session format
was strenuous and thus tiring for participants.
Concentration on the head-mounted VR display may
have contributed to this effect. Nevertheless, our
ﬁndings clearly warrant further investigation of the
effects of post-therapy sleep for all kinds of different
therapeutic settings.
The most crucial ﬁnding of our study was that sleep
facilitated the effects of exposure therapy in the long
run. Not only did participants who slept show less
fear at 1-week follow-up, they also reported a greater
drop in their most severe spider-related cognition com-
pared with those who remained awake. In contrast,
the wake group did not show any reduction in these
indices following the post-exposure measurement.
Exposure-based psychotherapy of phobia is thought
to rely on extinction of fear responses (Ressler et al.
2004; McNally, 2007), a learning mechanism that has
been shown to be signiﬁcantly delayed in phobias
and other anxiety disorders. In animals, the important
role of sleep for extinction learning is well established.
In honeybees, sleep after extinction learning improved
extinction memory as compared with sleep depri-
vation (Hussaini et al. 2009). Similarly in rats, particu-
larly REM sleep deprivation after extinction learning
had an impairing effect on extinction (Silvestri et al.
2001; Silvestri & Root, 2008). Also in humans,
REM sleep deprivation increased skin conductance
responses to previously extinguished fear cues
(Spoormaker et al. 2011). In addition, undisturbed
sleep after extinction learning (compared with wake-
fulness) in a classical conditioning paradigm promoted
the generalization of extinction of conditioned fear, but
did not directly affect extinction recall tested immedi-
ately after a sleep or waking interval (Pace-Schott
et al. 2009). The lack of immediate effects of sleep or
waking after extinction learning on extinction recall is
consistent with the results of the current study and
might be partly due to after-effects of prior sleep or
wakefulness on emotional reactivity during the testing
and recall phase (van der Helm et al. 2011a; van der
Helm & Walker, 2011; Baran et al. 2012). Sleep inertia
may deteriorate arousal and several cognitive perform-
ances in the post-awakening period (Wertz et al. 2006)
and may thus have inﬂuenced our results for the
immediate post-sleep measurement. Future studies
should thus employ additional tests to preclude such
effects. Most importantly, however, we show that
sleep after extinction learning during exposure therapy
is particularly beneﬁcial for long-term reduction of fear
to the phobic stimulus. A possible explanation is that
sleep after extinction learning initiates a process of
stabilization of the new extinction memory trace,
which continues to fully develop over multiple nights.
Beneﬁcial effects of sleep on emotional learning have
been observed up to 4 years (Wagner et al. 2006).
Fig. 1. Enhanced reduction in self-reported fear (range
0–100), fear-related negative cognition (range 0–100) and
behavioral avoidance (distance to a spider in cm) in the
sleep compared with the wake group. The 1-week change
scores were calculated by subtracting immediate follow-up
scores from 1-week follow-up scores. Values are means,
with standard errors represented by vertical bars. * Mean
value was signiﬁcantly different from that for the wake
group (p<0.05).
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In addition, the immediate effect of sleep on generaliz-
ation of extinction (Pace-Schott et al. 2009) might help
to transfer the positive effects of exposure treatment
to the real world and ‘real’ spiders, resulting in most
pronounced effects during follow-up testing. Finally,
the follow-up testing is not confounded by differences
in prior sleep or wakefulness, allowing testing both
experimental groups in similar states.
To shed light on the mechanism of action of
sleep, we explored the relationship between sleep indi-
ces and reductions in fear and cognition. We found a
speciﬁc relationship between fear and cognition
reduction and stage 2 sleep, but not REM sleep. As
we examined short naps in this study, the amount of
REM sleep was rather small in our sleep group
(mean duration 1.5 min), which might obscure possible
relationships between REM sleep and reductions
in fear. While studies support a role for REM sleep
in emotional learning processes (Silvestri et al.
2001; Wagner et al. 2001; Silvestri & Root, 2008;
Spoormaker et al. 2011) and have reported correlations
with emotional memory measures and REM sleep
(Nishida et al. 2009), others have also failed to ﬁnd
such relationships (Baran et al. 2012). An involvement
of stage 2 sleep in consolidation processes has been
proposed, particularly for simple motor tasks
(Walker et al. 2002, 2003; Smith et al. 2004), whereas
sleep spindles characterizing stage 2 sleep are believed
to play a crucial role in consolidation of several differ-
ent types of memories during sleep and are supposed
to promote plastic changes in cortical networks
together with hippocampal memory reactivations
(e.g. Rasch et al. 2007; Diekelmann & Born, 2010;
Mölle & Born, 2011). Thus, further studies are required
to specify the role of stage 2 sleep and sleep spindles in
memory processes related to fear extinction learning
occurring during sleep.
From a clinical perspective, our results indicate
that napping after therapy facilitates the effects of VR
exposure therapy. This is important, as not all patients
beneﬁt from exposure therapy, and for those who
beneﬁt, fear often returns following initially successful
therapy (Craske & Mystkowski, 2006). Napping
post-therapy may thus be one method for enhancing
exposure-based interventions in order to increase
response rates. Advising patients to nap following psy-
chotherapy may be beneﬁcial, as novel memories are
formed during a session and sleep may increase their
consolidation and possibly generalization (Nishida
et al. 2009; Pace-Schott, 2012).
Our study is an initial foray into an important
clinical application of recent memory research and
not without limitations. Future studies will be needed
to replicate the beneﬁcial effect of sleep, as well as
to extend it to other forms of psychotherapy.
In particular, it may be important to study multiple-
session rather than single-session therapies, and to
investigate the beneﬁcial effects of sleep on speciﬁc
therapies for different forms of psychopathology, e.g.
depression rather than anxiety disorders. It may also
be crucial to clarify the exact mechanisms by which
memory consolidation post-therapy takes place, and
whether and how this may be interacting with psycho-
pharmacological treatment. This may be particularly
important, as we did not assess possible interactions
between post-therapy sleep with night sleep following
therapy. The present study did not employ physiologi-
cal measures of arousal during the BAT and future
studies should include such measures. Finally, the
relatively short sleep period in our study may have
precluded longer REM periods. The lack of association
between REM sleep and reduction in anxiety may
therefore reﬂect a type II error.
Despite these limitations, our study has a number of
strengths. We demonstrated that individuals afﬂicted
with anxiety disorder are able to nap following one-
session exposure treatment, and that this short nap
beneﬁts emotional memory consolidation post-therapy
and thus enhances the effect of psychotherapy. These
ﬁndings offer an important non-invasive alternative
to recent attempts to facilitate therapeutic memory
extinction and consolidation processes with pharmaco-
logical interventions. Our ﬁndings help to understand
the memory processes in fear reduction. Given replica-
tion with longer follow-up time points and extension
to other samples and therapeutic settings, our data
may open new avenues for further increasing the
effectiveness of psychological therapies for anxiety
and possibly other disorders.
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